Hypofractionated Radiation Therapy for Glioblastoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Notwithstanding major improvements in treatment modalities, the prognosis of patients with glioblastoma is poor. Hypofractionated radiation therapy as an alternative of the standard 6-week regimen could be an attractive approach as an effort to prevent tumor cell repopulation and reduction the total treatment period promoting patient comfort and convenience.
Epistemonikos ID: 229c2cafbd31df52d9ad3f4ba6a128ce907f9e56
First added on: May 20, 2024